MIMEDX (MDXG) director William Hawkins receives 50,913-share restricted stock grant

Rhea-AI Filing Summary

HAWKINS WILLIAM A reported acquisition or exercise transactions in this Form 4 filing.

MIMEDX GROUP, INC. director William A. Hawkins received an annual restricted stock grant of 50,913 shares of common stock at $3.64 per share. This grant is compensation for his service as a non-employee director and is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. Following this grant, Hawkins directly holds 254,931 shares of MIMEDX common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HAWKINS WILLIAM A

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50,913	$3.64	$185K

Holdings After Transaction: Common Stock — 254,931 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 50,913 shares Grant price per share: $3.64 per share Shares held after grant: 254,931 shares +2 more

5 metrics

Restricted shares granted 50,913 shares Annual restricted stock grant to non-employee director

Grant price per share $3.64 per share Value used for restricted stock award

Shares held after grant 254,931 shares Total direct holdings after the transaction

Transaction code A (Grant, award, or other acquisition) Non-derivative acquisition of common stock

Transaction date June 10, 2026 Date of restricted stock grant

Key Terms

restricted stock, Rule 16b-3, non-employee directors, vests

4 terms

restricted stock financial

"Represents annual restricted stock grant to non-employee directors."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Rule 16b-3 regulatory

"Grant is exempt under Rule 16b-3."

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

non-employee directors financial

"Represents annual restricted stock grant to non-employee directors."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

vests financial

"The award vests upon the earlier of 12 months or the next meeting of shareholders."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAWKINS WILLIAM A

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT

(Street)

MARIETTA GEORGIA 30062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		50,913(1)	A	$3.64	254,931	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Remarks:

	/s/ William F. Hulse as attorney-in-fact for William A. Hawkins III	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MIMEDX (MDXG) director William A. Hawkins report?

William A. Hawkins reported receiving 50,913 shares of MIMEDX common stock as an annual restricted stock grant. The shares were awarded at $3.64 per share as compensation for his role as a non-employee director, not as an open-market purchase.

Is the William A. Hawkins Form 4 transaction for MDXG a stock purchase or a grant?

The Form 4 transaction for William A. Hawkins is a grant, not a market purchase. He received 50,913 restricted shares as an annual stock award to non-employee directors, with terms described as a grant exempt under Rule 16b-3 for director compensation.

How many MIMEDX (MDXG) shares does William A. Hawkins hold after this Form 4?

After the reported grant, William A. Hawkins directly holds 254,931 shares of MIMEDX common stock. This total includes the 50,913 restricted shares awarded on the transaction date and reflects his updated direct ownership position as shown in the Form 4 filing.

What are the vesting terms of the MDXG restricted stock granted to William A. Hawkins?

The restricted stock award to William A. Hawkins vests upon the earlier of 12 months or the next meeting of shareholders. These vesting conditions apply to the 50,913 shares granted as an annual restricted stock grant to a non-employee director of MIMEDX.

Why is the MIMEDX (MDXG) stock grant to William A. Hawkins exempt under Rule 16b-3?

The grant is described as exempt under Rule 16b-3 because it is an annual restricted stock award to a non-employee director. Rule 16b-3 provides an exemption for certain issuer-approved equity compensation transactions, such as director stock grants, from short-swing profit rules.

Did William A. Hawkins buy or sell any MIMEDX (MDXG) shares on the open market in this Form 4?

No open-market buys or sells are reported in this Form 4. The filing shows a single acquisition coded as a grant or award of 50,913 restricted shares to William A. Hawkins, with no reported sales or derivative exercises on the transaction date.